For those with SARS-CoV-2 infection, vaccinated participants had lower mean viral load, risk of febrile symptoms, illness duration
COVID-19 Falls From America’s No. 1 Killer to No. 7 by June
COVID-19 deaths have fallen sharply as vaccination rates have surged in recent months
Medication Type for T2DM May Affect Severe COVID-19 Outcomes
Premorbid GLP1-RA use, SGLT2i use associated with lower 60-day mortality compared to premorbid DPP4i use
Strategies ID’d Than Can Interrupt Spread of Infectious Disease
Key elements of effective system include border controls, restricted entry, quarantine for inbound travelers
16.8 Million Undiagnosed COVID-19 Cases in First Six Months in U.S.
Overall weighted undiagnosed seropositivity estimate was 4.6 percent, with estimates ranging from 1.1 to 14.2 percent by subgroup
Most Americans Who Wanted COVID-19 Vaccine Have Already Gotten One
Only 3 percent of those who have not been vaccinated said they plan to do so as soon as they can
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
LA County Recommends Masks for All When Indoors as Delta Variant Spreads
First identified in India, the Delta variant is now the third-most common in California
Mental Health Conditions Up in Public Health Workers During Pandemic
53.0 percent in public health departments reported symptoms of at least one condition in survey conducted during March, April 2021
Seven Cases of Guillain-Barré Noted After COVID-19 Vaccine in India
Second study describes four cases, which occurred 11 to 22 days after vaccination with COVID-19 Oxford-AstraZeneca vaccine